Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 6147-6151, Vol. 73, No. 7
McGill University AIDS Centre, Lady Davis
Institute-Jewish General Hospital, Montreal, Quebec, Canada H3T
1E2, and Department of Microbiology and Immunology, McGill
University, Quebec, Canada H3A 2B4
Received 28 December 1998/Accepted 1 April 1999
Previous work has shown that deletions of genomic segments at
nucleotide (nt) positions +238 to +253, i.e., construct BH10-LD3, or nt
positions +261 to +274, i.e., construct BH10-LD4, within the human
immunodeficiency virus type 1 (HIV-1) dimerization initiation site
(DIS) destroyed DIS secondary structure and dramatically reduced viral
replication capacity. Surprisingly, two point mutations located within
the viral peptide 2 (p2) and nucleocapsid (NC) protein termed MP2 and
MNC, respectively, were able to compensate for this defect. Since the
MP2 mutation involves an amino acid substitution near the cleavage site
between p2 and NC, we investigated the effects of the above-mentioned
deletions on the processing of Gag proteins. Immunoprecipitation assays
performed with monoclonal antibodies against viral capsid (CA) (p24)
protein showed that p2 was cleaved from CA with less efficiency in
viruses that contained the LD3 and LD4 deletions than in wild-type
viruses. The presence of the two compensatory mutations, MP2 and MNC,
increased the efficiency of the cleavage of p2 from CA, but neither
mutation alone had this effect or was sufficient to compensate for the observed impairment in infectiousness. A virus that contained both of
the above-mentioned deletions within the DIS was also impaired in
regard to processing and infectiousness, and it could likewise be
compensated by the MP2 and MNC point mutations. These results suggest
that the DIS region of HIV-1 RNA plays an important role in the
processing of Gag proteins.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Deletion Mutagenesis within the Dimerization
Initiation Site of Human Immunodeficiency Virus Type 1 Results in
Delayed Processing of the p2 Peptide from Precursor Proteins
*
Corresponding author. Mailing address: McGill AIDS
Centre, Jewish General Hospital, 3755, Chemin Côte-Ste-Catherine,
Montréal, Québec, Canada H3T 1E2. Phone: (514) 340-8307. Fax: (514) 340-7537. E-mail: mdwa{at}musica.mcgill.ca.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|